Neurobehavioral effects of dental amalgam in children - A randomized clinical trial

被引:164
作者
DeRouen, TA
Martin, MD
Leroux, BG
Townes, BD
Woods, JS
Leitao, J
Castro-Caldas, A
Luis, H
Bernardo, M
Rosenbaum, G
Martins, IP
机构
[1] Univ Washington, Sch Dent, Dept Dent Publ Hlth Sci, Seattle, WA 98195 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Washington, Dept Oral Med, Seattle, WA 98195 USA
[4] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[5] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[6] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA
[7] Battelle Ctr Publ Hlth Res & Evaluat, Seattle, WA USA
[8] Univ Lisbon, Fac Med Dent, P-1699 Lisbon, Portugal
[9] Univ Lisbon, Fac Med, P-1699 Lisbon, Portugal
[10] Univ Catolica Portuguesa, Inst Hlth Sci, Lisbon, Portugal
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 15期
关键词
D O I
10.1001/jama.295.15.1784
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Dental ( silver) amalgam is a widely used restorative material containing 50% elemental mercury that emits small amounts of mercury vapor. No randomized clinical trials have determined whether there are significant health risks associated with this low-level mercury exposure. Objective To assess the safety of dental amalgam restorations in children. Design A randomized clinical trial in which children requiring dental restorative treatment were randomized to either amalgam for posterior restorations or resin composite instead of amalgam. Enrollment commenced February 1997, with annual follow-up for 7 years concluding in July 2005. Setting and Participants A total of 507 children in Lisbon, Portugal, aged 8 to 10 years with at least 1 carious lesion on a permanent tooth, no previous exposure to amalgam, urinary mercury level < 10 mu g/L, blood lead level < 15 mu g/dL, Comprehensive Test of Nonverbal Intelligence IQ >= 67, and with no interfering health conditions. Intervention Routine, standard-of-care dental treatment, with one group receiving amalgam restorations for posterior lesions (n= 253) and the other group receiving resin composite restorations instead of amalgam ( n= 254). Main Outcome Measures Neurobehavioral assessments of memory, attention/ concentration, and motor/visuomotor domains, as well as nerve conduction velocities. Results During the 7-year trial period, children had a mean of 18.7 tooth surfaces ( median, 16) restored in the amalgam group and 21.3 ( median, 18) restored in the composite group. Baseline mean creatinine-adjusted urinary mercury levels were 1.8 mu g/g in the amalgam group and 1.9 mu g/g in the composite group, but during follow-up were 1.0 to 1.5 mu g/g higher in the amalgam group than in the composite group ( P <. 001). There were no statistically significant differences in measures of memory, attention, visuomotor function, or nerve conduction velocities ( average z scores were very similar, near zero) for the amalgam and composite groups over all 7 years of follow-up, with no statistically significant differences observed at any time point ( P values from .29 to .91). Starting at 5 years after initial treatment, the need for additional restorative treatment was approximately 50% higher in the composite group. Conclusions In this study, children who received dental restorative treatment with amalgam did not, on average, have statistically significant differences in neurobehavioral assessments or in nerve conduction velocity when compared with children who received resin composite materials without amalgam. These findings, combined with the trend of higher treatment need later among those receiving composite, suggest that amalgam should remain a viable dental restorative option for children.
引用
收藏
页码:1784 / 1792
页数:9
相关论文
共 23 条
[1]  
Agency for Toxic Substances and Disease Registry, 1999, TOX PROF MERC
[2]  
[Anonymous], 2005, Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics
[3]  
BOWERS MA, 1992, J LAB CLIN MED, V120, P272
[4]   Untitled [J].
Brown, R .
POLYMER TESTING, 2005, 24 (01) :1-1
[5]   RAPID METHOD FOR THE DETERMINATION OF TOTAL MERCURY IN URINE SAMPLES USING COLD VAPOR ATOMIC FLUORESCENCE SPECTROMETRY [J].
CORNS, WT ;
STOCKWELL, PB ;
JAMEEL, M .
ANALYST, 1994, 119 (11) :2481-2484
[6]   Issues in design and analysis of a randomized clinical trial to assess the safety of dental amalgam restorations in children [J].
DeRouen, TA ;
Leroux, BG ;
Martin, MD ;
Townes, BD ;
Woods, JS ;
Leitao, J ;
Castro-Caldas, A ;
Braveman, N .
CONTROLLED CLINICAL TRIALS, 2002, 23 (03) :301-320
[7]   Urinary mercury concentrations associated with dental restorations in adult women aged 16-49 years: United States, 1999-2000 [J].
Dye, BA ;
Schober, SE ;
Dillon, CF ;
Jones, RL ;
Fryar, C ;
McDowell, M ;
Sinks, TH .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2005, 62 (06) :368-375
[8]  
FRIBERG L, 1973, MERCURY MERCURIALS M
[9]   DISTRIBUTION OF GLUTATHIONE S-TRANSFERASE ISOENZYMES IN HUMAN-KIDNEY - BASIS FOR POSSIBLE MARKERS OF RENAL INJURY [J].
HARRISON, DJ ;
KHARBANDA, R ;
CUNNINGHAM, DS ;
MCLELLAN, LI ;
HAYES, JD .
JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (06) :624-628
[10]   Group sequential testing in dental clinical trials with longitudinal data on multiple outcome variables [J].
Leroux, BG ;
Mancl, LA ;
DeRouen, TA .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2005, 14 (06) :591-602